Purpose-built for physicians Increase in online searches for obesity drugs correlates with rise in prescriptions Key takeaways: Obesity drug prescriptions rose from 760,000 in July 2017 to 1.51 million in February 2024
Author contributions Conception and design of the study: SL and HF
These metabolites bind to Takeda G protein coupled receptor-5 TGR5 receptor (G-protein-coupled bile receptor) present in the endocrine glands, adipocytes, muscles, immune organs, spinal cord and enteric nervous system, and stimulates the secretion of incretin hormone GLP-1 and insulin
because I believe there is no happiness without good health. This is the simple, yet extraordinary vision of Mr Raajesh Dhuria, MD and CEO, a pharmaceutical leader with over three decades of experience not only in scaling up existing businesses in Multinational & Indian healthcare organisations but also creating new profitable ventures
3 and Supplementary Table 21)